Submission Details

Submitter:

Classification:
Disputed Evidence
GENCC:100005
Gene:
Disease:
chilblain lupus
Mode Of Inheritance:
Autosomal dominant
Evaluated Date:
02/25/2019
Evidence/Notes:
The SAMHD1 gene is located on chromosome 20 at 20q11.23 and encodes the SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1 protein. Through its role in the replication stress response, this protein prevents the induction of interferons and inflammation by limiting the release of single-stranded DNA from stalled replication forks. In addition, its dNTPase activity functions to reduce cellular dNTP levels and restrict viral infection. The SAMHD1 gene was first reported in relation to autosomal dominant chilblain lupus in 2011 (21204240: Ravenscroft et al. 2011). The clinical data supporting this association are limited to a single unconvincing case (Ravenscroft et al. 2011), as the same variant identified in the only reported case has also been reported in a heterozygous state in at least four unaffected individuals (19525956: Rice et al. 2009; 20653736: Ramesh et al. 2010; 30275001: Haskell et al. 2018). Of note, this gene has also been implicated in Aicardi-Goutieres syndrome. This will be assessed separately. In summary, there is convincing evidence disputing the association between SAMHD1 and autosomal dominant chilblain lupus. More evidence is needed to either support or refute the role SAMHD1 plays in this disease. Lumping and Splitting: Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern and phenotype. An assertion for an independent disease association has been made (21204240: Ravenscroft et al. 2011), but the autosomal dominant disorder of chilblain lupus has also been suggested to be a forme fruste of the primary autosomal recessive manifestation of Aicardi-Goutieres syndrome (AGS) (17357087: Rice et al. 2007; 27604406: Yarbrough et al. 2016). The phenotypes are largely distinct in that typical AGS is much more severe; however, chilblains are sometimes present in SAMHD1 AGS, and atypical AGS can result in a lupus-like phenotype. No difference in molecular mechanism has been asserted. For these reasons, we have split curations for the disease entities chilblain lupus and Aicardi-Goutieres syndrome.
PubMed IDs:
21204240 19525956 29670289
Assertion Criteria:
Submitter Submitted Date:
10/15/2020

The GenCC data are available free of restriction under a CC0 1.0 Universal (CC0 1.0) Public Domain Dedication. The GenCC requests that you give attribution to GenCC and the contributing sources whenever possible and appropriate. The accepted Flagship manuscript is now available from Genetics in Medicine (https://www.gimjournal.org/article/S1098-3600(22)00746-8/fulltext).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. The GenCC does not independently verify the submitted information. Though the information is obtained from sources believed to be reliable, no warranty, expressed or implied, is made regarding accuracy, adequacy, completeness, reliability or usefulness of any information. This disclaimer applies to both isolated and aggregate uses of the information. The information is provided on an "as is" basis, collected through periodic submission and therefore may not represent the most up-to-date information from the submitters. If you have questions about the medical relevance of information contained on this website, please see a healthcare professional; if you have questions about specific gene-disease claims, please contact the relevant sources; and if you have questions about the representation of the data on this website, please contact gencc@thegencc.org.